Hydrocortisone Patent Expiration
Hydrocortisone is Used for treating adrenal insufficiency. It was first introduced by Merck And Co Inc
Hydrocortisone Patents
Given below is the list of patents protecting Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Alkindi Sprinkle | US9649280 | Composition comprising hydrocortisone | May 12, 2034 | Eton |
Alkindi Sprinkle | US9675559 | Treatment of adrenal insufficiency | Jan 10, 2033 | Eton |
Alkindi Sprinkle | US9717740 | Treatment of adrenal insufficiency | Nov 19, 2032 | Eton |
Hydrocortisone's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List